InvestorsHub Logo
Followers 10
Posts 1765
Boards Moderated 0
Alias Born 09/19/2019

Re: None

Wednesday, 06/09/2021 9:48:22 AM

Wednesday, June 09, 2021 9:48:22 AM

Post# of 113741
Wed, June 9, 2021, 4:17 AM

MRK
+1.94%
(Adds details on rival antiviral drugs, background)

June 9 (Reuters) - Merck & Co Inc said on Wednesday the U.S. government has agreed to pay about $1.2 billion for 1.7 million courses of its experimental COVID-19 treatment, if it is proven to work in an ongoing large trial and authorized by U.S. regulators.

The oral antiviral treatment, molnupiravir, aims to stop COVID-19 from progressing and can be given early in the course of the disease, similar to Tamiflu to treat influenza.

The treatment course being tested in the trial is an oral dose given every 12 hours for five days.

How will lil'ole SUNSHINE stand a chance?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News